A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)
Clinical trial NCT04200456 · TERMINATED
Trial details
- NCT number
- NCT04200456
- Sponsor
- UCB Biopharma SRL
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-31
- Primary completion
- 2022-03-21
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.